News for Aptinyx Inc. (APTX)

SAN DIEGO — Tentarix Biotherapeutics today announced the appointment of Andrew Kidd, MD, as chief executive officer. Mr. Kidd joins Tentarix with a…

Key fibromyalgia treatment market players include Pfizer Inc., AbbVie Inc., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Aptinyx...

The global fibromyalgia treatment market is poised for significant growth in the coming years, driven by a growing awareness of the condition, increasing...

The dynamics of the Hunter syndrome market are anticipated to change in the coming years owing to the launch of emerging therapies and improvement in...

The future of the fibromyalgia treatment market is promising, with pharmaceutical companies actively researching and developing new medications that can...

The overall frontotemporal dementia market is expected to rise due to increasing prevalence cases over the globe and thus the surge in treatment options....

/PRNewswire/ -- DelveInsight's Mucopolysaccharidosis Market Insights report includes a comprehensive understanding of current treatment practices,...

NEW YORK, July 06, 2023 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the ordinary shares of Puhui Wealth Investment...

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.34%

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.65%

Parkinson's disease is a progressive disorder that is caused by the degeneration of nerve cells in the part of the brain called the substantia nigra, which...

GuruFocus Article or News written by insider and the topic is about:

/PRNewswire/ -- According to Coherent Market Insights, the global fibromyalgia treatment market is estimated to be valued at US$ 3,142.4 million in 2022 and is...

Gainers

This article focuses on the influences towards a biotech company's share price, rather than their value. Read what to know about biotech catalysts here.